Status:
RECRUITING
Mobile Application to Collect PRO Data in NET Patients
Lead Sponsor:
King's College Hospital NHS Trust
Collaborating Sponsors:
Ampersand Health Ltd
Neuroendocrine Cancer UK
Conditions:
Neuroendocrine Neoplasms (Tumours)
Eligibility:
All Genders
18+ years
Brief Summary
Observational trial to assess the feasibility of monitoring patient reporting symptoms via mobile devices
Detailed Description
Neuroendocrine tumours (NET) are uncommon cancers with varied presentation. Patients are treated in specialist centres, and may sometimes have up to 4 lines of treatment; with the attendant complicati...
Eligibility Criteria
Inclusion
- Histologically confirmed diagnosis of a NET
- Planned treatment for NET
- Able to give informed consent
- Able to understand the language of the questionnaires
- A minimum expected survival of 6 months
- All performance status is acceptable
- 18 years of age or over
Exclusion
- Concurrent malignancies for which they are undergoing treatment
- No smartphone / device
- Any physical, psychological or comprehension problems that prevents completion of questionnaires.
Key Trial Info
Start Date :
July 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04324502
Start Date
July 20 2020
End Date
July 1 2026
Last Update
November 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
King's College Hospital
London, United Kingdom, SE5 9RS